Aridis Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Summary

Aridis Pharmaceuticals LLC (Aridis) is a biotechnology company that utilizes proprietary technologies for producing anti-infectives and vaccines for infectious diseases. The companys human monoclonal antibody discovery platform technology MabIgX is used for facilitating the development of natural, fully human antibodies into medicines, while circumventing the conventional genetic and recombinant DNA steps. It develops a range of human monoclonal antibodies into anti-infective drugs targeting critical human pathogens including S, current trajectory of increasing antibiotics resistance and improve the health outcome of many of the most serious life-threatening infections particularly in hospital settings. The company also works on macromolecular stabilization technology for increase the stability of vaccines. Aridis is headquartered in San Jose, California, the US.

Aridis Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

2
List of Tables 3
List of Figures 4
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Aridis Pharma Acquires Monoclonal Antibody Products And Technologies From Kenta Biotech 10
Venture Financing 11
Aridis Pharma Raises USD13.6 Million in Venture Financing 11
Aridis Pharma Raises USD15.2 Million in Financing Round 12
Aridis Pharma Raises USD3 Million Financing 13
Partnerships 13
Aridis Pharma Enters Into Co-Development Agreement For Vaccine Formulation 13
Equity Offering 14
Aridis Pharma Raises USD6.75 Million in Private Placement of Shares 14
Aridis Pharmaceuticals LLC - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Apr 18, 2016: Aridis Pharmaceuticals Strengthens Board of Directors with Former Wyeth (now Pfizer) President of R&D Robert Ruffolo, Jr. 18
Clinical Trials 19
Jan 07, 2016: Aridis Pharmaceuticals Reports Positive Phase 1 Clinical Results for Aerucin for Treating Hospital-Acquired and Ventilator-Associated Pneumonia 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables


Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Key Facts 1
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aridis Pharmaceuticals LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aridis Pharma Acquires Monoclonal Antibody Products And Technologies From Kenta Biotech 10
Aridis Pharma Raises USD13.6 Million in Venture Financing 11
Aridis Pharma Raises USD15.2 Million in Financing Round 12
Aridis Pharma Raises USD3 Million Financing 13
Aridis Pharma Enters Into Co-Development Agreement For Vaccine Formulation 13
Aridis Pharma Raises USD6.75 Million in Private Placement of Shares 14
Aridis Pharmaceuticals LLC, Key Competitors 15
Aridis Pharmaceuticals LLC, Key Employees 16

List Of Figures


Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aridis Pharmaceuticals LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Aridis Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aridis Pharmaceuticals Inc (Aridis) is a biopharmaceutical companythat focusses on development of novel, differentiated therapies for infectious diseases. The companys pipeline product uses disruptive platform technology to discover potent human

USD 250 View Report

Aridis Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Aridis Pharmaceuticals LLC (Aridis) is a biotechnology company that utilizes proprietary technologies for producing anti-infectives and vaccines for infectious diseases. The companys human monoclonal antibody discovery platform technology MabIgX is

USD 250 View Report

Aprecia Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aprecia Pharmaceuticals LLC (Aprecia Pharmaceuticals) is a drug delivery technology platform company that develops pharma-ready patient-centric products. The company offers Zipdose technology, a delivery platform that serves as the foundation

USD 250 View Report

Machavert Pharmaceuticals LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Machavert Pharmaceuticals LLC (Machavert Pharmaceuticals) is a bio-pharmaceutical company which develops novel non-toxic medicines for the treatment of cancer and autoimmune diseases. Its lead drug candidate MP1000, a nanoparticulate liposomal

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available